Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma

Hippo/YAP1 signaling is a major regulator of organ size, cancer stemness, and aggressive phenotype. Thus, targeting YAP1 may provide a novel therapeutic strategy for tumors with high YAP1 expression in esophageal cancer (EC). Chromatin immunoprecipitation (ChiP) and quantitative ChiP‐PCR were used t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Oncol
Autors principals: Song, Shumei, Li, Yuan, Xu, Yan, Ma, Lang, Pool Pizzi, Melissa, Jin, Jiankang, Scott, Ailing W, Huo, Longfei, Wang, Ying, Lee, Jeffrey H., Bhutani, Manoop S., Weston, Brian, Shanbhag, Namita D, Johnson, Randy L., Ajani, Jaffer A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266288/
https://ncbi.nlm.nih.gov/pubmed/32175692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12667
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars